Acadia Pharmaceuticals Inc (ACAD) insider trading
Every open-market stock purchase and sale by Acadia Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Mark C. Schneyer (CFO) and 1 other sold $1M in the last 90 days.
- Last insider buy: Baker Bros. Advisors LP (10% owner), $6.6M, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $3.4M (17 sales). Last close $29.21 on Aug 7, 2026.
Recent ACAD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 6, 2026 | Mark C. Schneyer (CFO) | Sold | $273K |
| Aug 6, 2026 | Mark C. Schneyer (CFO) | Sold | $145K |
| Aug 6, 2026 | Mark C. Schneyer (CFO) | Bought (not open market) | — |
| Aug 5, 2026 | Mark C. Schneyer (CFO) | Sold | $170K |
| Aug 5, 2026 | Mark C. Schneyer (CFO) | Bought (not open market) | — |
| Jul 30, 2026 | Elizabeth H.Z. Thompson (VP) | Sold | $431K |
| Jul 30, 2026 | Elizabeth H.Z. Thompson (VP) | Sold | $1.3K |
| Jul 29, 2026 | Elizabeth H.Z. Thompson (VP) | Bought (not open market) | — |
| Jun 26, 2026 | James Kihara (Insider) | Sold | $298K |
| May 29, 2026 | James M Daly (Insider) | Bought (not open market) | — |
| May 29, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| May 29, 2026 | Jonathan Poole (Insider) | Bought (not open market) | — |
| May 29, 2026 | Adora Ndu (Insider) | Bought (not open market) | — |
| May 29, 2026 | James M Daly (Insider) | Bought (not open market) | — |
| May 29, 2026 | Edmund Harrigan (Insider) | Bought (not open market) | — |
| May 29, 2026 | Adora Ndu (Insider) | Bought (not open market) | — |
| May 29, 2026 | Elizabeth A. Garofalo (Insider) | Bought (not open market) | — |
| May 29, 2026 | Elizabeth A. Garofalo (Insider) | Bought (not open market) | — |
| May 29, 2026 | Laura Brege (Insider) | Bought (not open market) | — |
| May 29, 2026 | Laura Brege (Insider) | Bought (not open market) | — |
| May 29, 2026 | Laura Brege (Insider) | Bought (not open market) | — |
| May 29, 2026 | Baker Bros. Advisors LP (Insider) | Bought (not open market) | — |
| May 29, 2026 | Edmund Harrigan (Insider) | Bought (not open market) | — |
| May 29, 2026 | Elizabeth A. Garofalo (Insider) | Bought (not open market) | — |
| May 29, 2026 | Edmund Harrigan (Insider) | Bought (not open market) | — |
Who's trading ACAD
- Mark C. Schneyer, CFO: sold $1.1M (9 sales), last Aug 6, 2026
- Elizabeth H.Z. Thompson, VP: sold $506K (3 sales), last Jul 30, 2026
- James Kihara, Insider: sold $603K (8 sales), last Jun 26, 2026
- Baker Bros. Advisors LP, Insider: other filings, last May 29, 2026
- James M Daly, Insider: sold $671K (1 sale), last May 29, 2026
- Elizabeth A. Garofalo, Insider: other filings, last May 29, 2026
- Edmund Harrigan, Insider: other filings, last May 29, 2026
- Adora Ndu, Insider: other filings, last May 29, 2026
- Jonathan Poole, Insider: other filings, last May 29, 2026
- Laura Brege, Insider: other filings, last May 29, 2026
- Adams Catherine Owen, CEO: sold $250K (1 sale), last Mar 25, 2026
- Jennifer J Rhodes, C-suite exec: sold $245K (2 sales), last Mar 25, 2026
- Thomas Garner, C-suite exec: other filings, last Mar 6, 2026
Get free alerts when an insider at Acadia Pharmaceuticals Inc files a new trade →